Liquid Biopsy Labs

Liquid Biopsy Labs

生物技术

The future of cancer management in a simple blood test.

关注

关于我们

The first liquid biopsy – in the world – to test for an almost INFINITE number of mutations. The only liquid biopsy to provide accurate cancer treatment monitoring. With Liquid Biopsy Labs, every cancer patient can easily have a highly targeted treatment plan. About LBL: Precision oncology should not include guessing or hoping – it should include the most accurate diagnosis possible through medical science today. With Liquid Biopsy Labs’ unique, personalized, and precise testing protocol, you’ll have true confidence in your cancer treatment plan. From start to finish, our testing protocol is designed for certainty. And, we can test for almost any mutation. Most liquid biopsy tests can only effectively be used for discovery. Because of limitations in their design, standard liquid biopsy tests only show if a patient has a mutation in their blood – meaning that, at best, standard liquid biopsy can be used to confirm what has already been identified in any genetic tumor tissue test. In other words, if you choose a targeted treatment based on the results of a standard liquid biopsy test, your ‘targeted’ therapy is actually more like a shot in the dark, or perhaps a ‘best guess’. You might get it right, but you may also be completely wrong. After nine years of researching many different liquid biopsy tests from around the world – and exploring combinations of additional diagnostics – research scientist Alexander Rolland (co-founder of Liquid Biopsy Labs), has designed a test that can confidently be used for both discovery and monitoring how well a treatment is working. Our unique, patent-pending test quantitatively measures the amount of a tumor-causing mutation in the blood. Read more to discover how Liquid Biopsy Labs' revolutionary liquid biopsy test can show if your patient's tumor is growing, slowing, or gone – with 99+% accuracy! www.liquidbiopsylabs.com

网站
https://liquidbiopsylabs.com/
所属行业
生物技术
规模
2-10 人
类型
私人持股
创立
2018
领域
Liquid Biopsy、Cancer Diagnosis、Cancer Screening、Targeted Treatment Recommendations、Cancer Treatment Monitoring、Genetic Testing、ctDNA、cfDNA、Exosome、Exosome-Based Liquid Biopsies、Oncogenomics、Precision Oncology、Precision Medicine、Clinical Application和Cancer Research

Liquid Biopsy Labs员工

查看全部员工

动态

相似主页

查看职位